NCT04432207 2024-11-07A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung CancerImugene LimitedPhase 1 Unknown24 enrolled
NCT03835949 2022-04-01Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic CancerTracon Pharmaceuticals Inc.Phase 1 Unknown36 enrolled